Abstract
A number of advances have been made in the adjuvant management of resectable rectal cancer. In patients with clinically resectable disease, pelvic radiation therapy decreases local recurrence and, in the preoperative setting, increases the chance of sphincter preservation. The addition of systemic chemotherapy further enhances local control and improves survival. The potential additional benefits of preoperative radiation therapy (with or without chemotherapy) include enhanced sphincter preservation and less toxicity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Minsky B.D. Management of locally advanced/unresectable rectal cancer. Radiat Oncol Invest 1995;3:97–107.
Minsky B.D., Cohen A.M., Enker W.E., et al. Combined modality therapy of rectal cancer: decreased acute toxicity with the pre-operative approach. J Clin Oncol 1992;10:1218–24.
Maghfoor I, Wilkes J, Kuvshinoff B, et al. Neoadjuvant chemoradiotherapy with sphincter-sparing surgery for low lying rectal cancer [sbstract]. Proc ASCO 1997;16:274.
Wagman R, Minsky B.D., Cohen A.M., Guillem J.G., Paty P.B. Sphincter preservation with pre-operative radiation therapy (RT) and colo anal anastomosis: long term follow-up [abstract]. Int J Radiat Oncol Biol Phys 1997;39:167.
Grann A, Minsky B.D., Cohen A.M., et al. Preliminary results of pre-operative 5-fluorouracil (5-FU), low dose leucovorin, and concurrent radiation therapy for resectable T3 rectal cancer. Dis Colon Rectum 1997;40:515–22.
Rouanet P, Fabre J.M., Dubois J.B., et al. Conservative surgery for low rectal carcinoma after high-dose radiation. Functional and oncologic results. Ann Surg 1995;221:67–73.
Hyams D.M., Mamounas E.P., Petrelli N, et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum. A progress report of the National Surgical Adjuvant Breast and Bowel Project protocol RO-3. Dis Colon Rectum 1997;40:131–39.
Koehler P.R., Feldberg M.A.M., van Waes P.F.G.M. Preoperative staging of rectal cancer with computerized tomography. Accuracy, efficacy, and effect on patient management. Cancer 1984;54:512–16.
Hadfield M.B., Nicholson A.A., MacDonald A.W., et al. Preoperative staging of rectal carcinoma by magnetic resonance imaging with a pelvic phased-array coil. Br J Surg 1997;84:529–31.
de Souza N.M., Hall A.S., Puni R, Gilderdale D.J., Young I.R., Kmiot W.A. High resolution magnetic resonance imaging of the anal sphincter using a dedicated endoanal coil. Comparison of magnetic resonance imaging with surgical findings. Dis Colon Rectum 1996;39:926–34.
Hunerbein M, Schlag P.M. Three-dimensional endosonography for staging of rectal cancer. Ann Surg 1997;25:432–38.
Milsom J.W., Czyrko C, Hull T.L., Strong S.A., Fazio V.W. Preoperative biopsy of pararectal lymph nodes in rectal cancer using endoluminal ultrasonography. Dis Colon Rectum 1994;37:364–68.
Falk P.M., Gupta N.C., Thorson A.G., et al. Positron emission tomography for preoperative staging of colorectal carcinoma. Dis Colon Rectum 1994;37:153–56.
Bernini A, Deen K.I., Madoff R.D., Wong W.D. Preoperative adjuvant radiation with chemotherapy for rectal cancer: its impact on stage of disease and the role of endorectal ultrasound. Ann Surg Oncol 1996;3:131–35.
Willett C.G., Warland G, Co en J., Shellito P.C., Compton C.C. Rectal cancer: the influence of tumor proliferation on response to preoperative irradiation. Int J Radiat Oncol Biol Phys 1995;32:57–61.
Willett C.G., Warland G, Hagan M.P., et al. Tumor proliferation in rectal cancer following preoperative irradiation. J Clin Oncol 1995;13:1417–24.
Desai G.R., Meyerson R.J., Higashikubo R, et al. Carcinoma of the rectum: possible cellular predictors of metastatic potential and response to radiation therapy. Dis Colon Rectum 1996;39:1090–96.
Neoptolemos J.P., Oates G.D., Newbold K.M., Robson A.M., McConkey C., Powell J. Cyclin/proliferation cell nuclear antigen immunohistochemistry does not improve the prognostic power of Dukes’ or Jass’ classifications for colorectal cancer. Br J Surg 1995;82:184–87.
Rich T.A., Sinicrope F, Stephens C, et al. Downstaging of T3 rectal cancer after preoperative infusional chemoradiation is correlated with spontaneous apoptosis index and BCL-2 staining [abstract]. Int J Radiat Oncol Biol Phys 1996;36:259.
Berger C, de Muret A, Garaud P, et al. Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor density (RTCD): prognostic implications. Int J Radiat Oncol Biol Phys 1997;37:619–27.
Zlotecki R.A., Mendenhall W.M., Copeland E.M., et al. Preoperative radiotherapy for resectable rectal cancer: improved local control is prognostic for distant metastasis occurrence and survival [abstract]. Int J Radiat Oncol Biol Phys 1996;36:261.
Myerson R.J., Michalski J.M., King M.L., et al. Adjuvant radiation therapy for rectal carcinoma: predictors of outcome. Int J Radiat Oncol Biol Phys 1995;32:41–50.
Bannon J.P., Marks G.J., Mohiuddin M, Rakinic J, Nong-Zhou J, Nagle D. Radical and local excisional methods of sphinctersparing surgery after high-dose radiation for cancer of the distal 3 em of the rectum. Ann Surg Oncol 1995;2:221–27.
Bosset J.F., Pavy J.J., Hamers H.P., et al. Determination of the optimal dose of 5-fluorouracil when combined with low dose d,l-leucovorin and irradiation in rectal cancer: results of three consecutive Phase II studies. Eur J Cancer 1993;29:476–86.
Pahlman L, Glimelius B. Pre-or postoperative radiotherapy in rectal and rectosigmoid carcinoma: report from a randomized multicenter trial. Ann Surg 1990;211:187–95.
Frykholm G.J., Glimelius B, Pahlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 1993;36:564–72.
Boulis-Wassif S, Gerard A, Loygue J, Camelot D, Buyse M, Duez N. Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery. Cancer 1984;53:1811–18.
Minsky B.D. Multidisciplinary management of resectable rectal cancer. Oncology 1996;10:1701–14.
Chari R.S., Tyler D.S., Anscher M.S., et al. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg 1995;221:778–87.
Stryker S.J., Kiel K.D., Rademaker A, Shaw J.M., Ujiki G.T., Poticha S.M. Preoperative “chemoradiation” for Stages II and II rectal carcinoma. Arch Surg 1996;131:514–19.
Rich T.A., Skibber J.M., Ajani J.A., et al. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 1995;32:1025–29.
Rich T.A. Infusional chemoradiation for operable rectal cancer: post-, pre-, or nonoperative management? Oncology 1997;11:295–315.
Gerard A, Buyse M, Nordlinger B, et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Ann Surg 1988;208:606–16.
Cedermark B, Johansson H, Rutqvist L.E., Wilking N. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. Cancer 1995;75:2269–75.
Higgins G.A., Humphrey E.W., Dwight R.W., Roswit B., Lu L.E. Jr, Keehn R.J. Preoperative radiation and surgery for cancer of the rectum: Veterans Administration Surgical Oncology Group trial II. Cancer 1986;58:352–59.
Rider W.D., Palmer J.A., Mahoney L.J., Robertson C.T. Preoperative irradiation in operable cancer of the rectum: report of the Toronto Trial. Can J Surg 1977;20:335–38.
Roswit B, Higgins G.A. Jr, Keehn R. Preoperative irradiation for carcinoma of the rectum and rectosigmoid colon: report of a national Veterans Administration randomized study. Cancer 1975;35:1597–602.
Duncan W. Adjuvant radiotherapy in rectal cancer: the MRC trials. Br J Surg 1985;72:S59–S62.
Reis Neto J.A., Quilici F.A., Reis J.A. Jr. A comparison of nonoperative vs preoperative radiotherapy in rectal carcinoma: a 10 year randomized trial. Dis Colon Rectum 1989;32:702–10.
Cedermark B. The Stockholm II trial on preoperative short term radiotherapy in operable rectal carcinoma: a prospective randomized trial [abstract]. Proc ASCO 1994;13:198.
Swedish Rectal Cancer Trial. Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal cancer. Br J Surg 1993;80:1333–37.
Swedish Rectal Cancer Trial. Local recurrence rate in a randomized multicentre trial of preoperative radiotherapy compared to surgery alone in resectable rectal cancer. Eur J Surg 1996;162:397–402.
Goldberg P.A., Nicholls R.J., Porter N.H., Love S, Grimsey J.E. Long-term results of a randomized trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: reduction in local treatment failure. Eur J Cancer 1994;30A: 1602–606.
Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997;336:980–87.
Medical Research Council Rectal Cancer Working Party. Randomized trial of surgery alone versus radiotherapy followed by surgery for potentially operable, locally advanced rectal cancer. Lancet 1996;348:1605–609.
Glimelius B, Isacson U, Jung B, Pahlman L. Radiotherapy in addition to radical surgery in rectal cancer: evidence for a dose-response effect favoring preoperative treatment. Int J Radiat Oncol Biol Phys 1997;37:281–87.
Holm T, Rutqvist L.E., Johansson H, Cedermark B. Postoperative mortality in rectal cancer treated with or without preoperative radiotherapy: causes and risk factors. Br J Surg 1996;83:964–68.
Frykholm G.J., Isacsson U., Nygard K, et al. Preoperative radiotherapy in rectal carcinoma: aspects of acute adverse effects and radiation technique. Int J Radiat Oncol Biol Phys 1996;35:1039–48.
Holm T, Singnomklao T, Rutqvist L.E., Cedermark B. Adjuvant preoperative radiotherapy in patients with rectal carcinoma. Adverse effects during long term follow-up of two randomized trials. Cancer 1996;78:968–76.
Graf W., Dahlberg M, Osman M.M., Holmberg L., Pahlman L, Glimelius B. Short-term preoperative radiotherapy results in down-staging of rectal cancer: a study of 1316 patients. Radiother Oncol 1997;43:133–37.
Mohiuddin M, Marks J, Bannon J. High-dose preoperative radiation and full thickness local excision: a new option for selected T3 distal rectal cancer. Int J Radiat Oncol Biol Phys 1994;30:845–49.
Papilion J, Gerard J.P. Role of radiotherapy in anal preservation for cancers of the lower third of the rectum. Int J Radiat Oncol Biol Phys 1990;19:1219–20.
Minsky B.D., Cohen A.M., Enker W.E., Paty P. Sphincter preservation with preoperative radiation therapy and coloanal anastomosis. Int J Radiat Oncol Biol Phys 1995;31: 553–59.
National Institutes of Health Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444–50.
Kollmorgen C.F., Meagher A.P., Pemberton J.H., Martenson J.A., Ilstrup D.M. The long term effect of adjuvant postoperative chemoradiotherapy for rectal cancer on bowel function. Ann Surg 1994;220:676–82.
Paty P.B., Enker W.E., Cohen A.M., Minsky B.D., FriedlanderKlar H. Long-term functional results of coloanal anastomosis for rectal cancer. Am J Surg 1994;167:90–95.
Birnbaum E.H., Dreznik Z, Myerson R.J., et al. Early effect of external beam radiation on anal sphincter; a study using anal manometry and transrectal ultrasound. Dis Colon Rectum 1992;35:757–61.
Birnbaum E.H., Meyerson R.J., Fry R.D., Kodner I.J., Fleshman J.W. Chronic effects of pelvic radiation therapy on anorectal function. Dis Colon Rectum 1994;37:909–15.
Minsky B.D. Adjuvant therapy for rectal cancer: results and controversies. Oncology 1998;12:1129–39.
MacFarlane J.K., Ryall R.D., Heald R.J. Mesorectal excision for rectal cancer. Lancet 1993;341:457–60.
Enker W.E., Thaler H.T., Cranor M.L., Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coli Surg 1995;181:335–45.
Haas-Kock D.F.M., Baeten C.G.M.I., Jager J.J., et al. Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg 1996;83:781–85.
Karanjia N.D., Corder A.P., Bearn P, Heald R.J. Leakage from stapled low anastomosis after total mesorectal excision for carcinoma of the rectum. Br J Surg 1995;81:1224–26.
Aitken R.J. Mesorectal excision for rectal cancer. Br J Surg 1996;83:214–16.
Withers H.R. Biological basis for altered fractionation schemes. Cancer 1985;55:2086–95.
Coucke P.A., Cuttat J.F., Mirimanoff R.O. Adjuvant postoperative accelerated hyperfractionated radiotherapy in rectal cancer: a feasibility study. Int J Radiat Oncol BioL Phys 1993;27:885–89.
Coucke P.A., Sartorelli B., Cuttat J.F., Jeanneret W., Gillet M., Mirimanoff R.O. The rationale to switch from postoperative hyperfractionated accelerated radiotherapy to preoperative hyperfractionated accelerated radiotherapy in rectal cancer. Int J Radiat Oncol Biol Phys 1995;32:181–88.
Tait D.M., Nahum A.E., Meyer L.C., et al. Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment. Radiother Oncol 1997;42:121–36.
Duncan W., Arnott S.J., Jack W.J.L., Orr J.A., Kerr G.R., Williams J.R. Results of two randomized trials of neutron therapy in rectal adenocarcinoma. Radiother Oncol 1987;8: 191–98.
Ichikawa D, Yamaguchi T, Yoshioka Y, Sawai K, Takahashi T. Prognostic evaluation of preoperative combined treatment for advanced cancer in the lower rectum with radiation, intraluminal hyperthermia, and 5-fluorouracil suppository. Am J Surg 1996;171:346–50.
Ohno S., Tomoda M., Tomisaki S, et al. Improved surgical results after combining preoperative hyperthermia with chemotherapy and radiotherapy for patients with carcinoma of the rectum. Dis Colon Rectum 1997;40:401–406.
Liu T., Liu Y., He S., Zhang Z., Kligerman M.M. Use of radiation with or without WR-2721 in advanced rectal cancer. Cancer 1992;69:2820–25.
Stelzer K.J., Koh W.J., Kurtz H, Greer B.E., Griffin T.W. Caffeine consumption is associated with decreased severe late toxicity after radiation to the pelvis. Int J Radiat Oncol Biol Phys 1994;30:411–17.
Rhomberg W, Eiter H, Hergan K, Schneider B. Inoperable recurrent rectal cancer: results of a prospective trial with radiation therapy and razoxane. Int J Radiat Oncol Biol Phys 1994;30:419–25.
Tatsuzaki H, Urie M.M., Willett C.G. 3-D comparative study of proton vs X-ray radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 1991;22:369–74.
Isacsson U, Montelius A, Jung B, Glimelius B. Comparative treatment planning between proton and X-ray therapy in locally advanced rectal cancer. Radiother Oncol 1997;41:263–72.
Pitot H.C., Wender D.B., O’Connell M.J., et al. Phase II trial of irinotecan in patients with metastatic colorectal carcinoma. J Clin Oncol 1997;15:2910–19.
Cunningham D, Zalcberg J.R., Rath U, et al. Final results of a randomised trial comparing “Tomudex” (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. Ann Oncol 1996;961:961–65.
Saltz L.B., Leichman C.G., Young C.W., et al. A fixed-ratio combination of uracil and ftorafur (UFT) with low dose leucovorin. Cancer 1995;75:782–85.
Gorlick R, Metzger R, Danenberg K, et al. Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma. J Clin Oncol 1998;16:1465–69.
Botwood N, James R, Vernon C, Price P. A Phase I study of “Tomudex” (raltitrexed) with radiotherapy (RT) as adjuvant treatment in patients (pt) with operable rectal cancer [abstract]. Proc ASCO 1998;17:277.
Rich T.A., Kirichenko A.V. Camptothecin radiation sensitization: mechanisms, schedules, and timing. Oncology 1998;12:114–19.
Marsh R.W., Chu N.M., Vauthey I.N., et al. Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy. Cancer 1996;78:217–25.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag London
About this chapter
Cite this chapter
Minsky, B.D., Köhne, CH., Greco, C. (2001). Neo-adjuvant Therapy. In: Audisio, R.A., Geraghty, J.G., Longo, W.E. (eds) Modern Management of Cancer of the Rectum. Springer, London. https://doi.org/10.1007/978-1-4471-0331-8_5
Download citation
DOI: https://doi.org/10.1007/978-1-4471-0331-8_5
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1070-5
Online ISBN: 978-1-4471-0331-8
eBook Packages: Springer Book Archive